Eupantol and hepatic failure Patient Reports February 10, 2010

Eupantol Side Effects Report #4743942-X
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on July 29, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: coagulation factor v level decreased, cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, prothrombin level decreased. Eupantol dosage: 40 MG 1X PER 1 DAY. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient died.

Eupantol Side Effects Report #4765850-0
Eupantol side effect was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2005. Female patient, 81 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, haemoglobin decreased, hepatic artery thrombosis, hepatic failure, hyperammonaemia, lactic acidosis, platelet count decreased, renal failure. Eupantol dosage: 40 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CANCIDAS, SYNERCID, TARGOCID. Patient was hospitalized. Patient died.

Eupantol Side Effects Report #4708531-1
Eupantol side effect was reported by a Health Professional from FRANCE on June 24, 2005. Male patient, 45 years of age, was treated with Eupantol. After drug was administered, patient experienced the following side effects: carnitine deficiency, haemorrhage, hepatic failure, hepatitis fulminant, lactic acidosis, lung disorder, shock. Eupantol dosage: unknown. During the same period patient was treated with AZACTAM, VANCOMYCIN, ZYVOX, CANCIDAS. Patient was hospitalized. Patient died.